logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Cti Biopharma Corp.

Calculating rank
USPTO Granted Patents = 8



Trademarks = 13

Forward Citations = 3

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Anthony Deodaunia William (7 out of 11 patents)

silverMedal Brian William Dymock (4 out of 20 patents)

bronzeMedal Stephanie Eliane Blanchard (3 out of 13 patents)

4.  Harish Kumar Mysore Nagaraj (3 out of 7 patents)

5.  Anders Poulsen (3 out of 12 patents)

6.  Yee Ling Evelyn Tan (3 out of 7 patents)

7.  Eric T Sun (3 out of 19 patents)

8.  Cheng Hsia Angeline Lee (3 out of 7 patents)

9.  Cheng H Lee (3 out of 3 patents)

10.  Cheng Hsia Angelina Lee (1 out of 1 patent)

11.  Valeria Livi (1 out of 9 patents)

12.  Alberto Bernareggi (1 out of 9 patents)

13.  Stéphanie Blanchard (1 patent)

14.  Brian Dymock (1 patent)

15.  Claudio Anasetti (1 patent)


8 patents:

1. 11135227 - Oxygen linked pyrimidine derivatives (2021-10-05),
2. 10517876 - Oxygen linked pyrimidine derivatives (2019-12-31),
3. 9624242 - 11-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt (2017-04-18),
4. 9573964 - Oxygen linked pyrimidine derivatives (2017-02-21),
5. 9211262 - Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity (2015-12-15),
6. 9062074 - (9E)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt (2015-06-23),
7. 8987243 - 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt (2015-03-24),
8. 8980873 - 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt (2015-03-17),
Company Overview
CTI BioPharma Corp. is a biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers. The company is dedicated to improving the lives of patients by advancing innovative treatments that address unmet medical needs. With a diverse pipeline of promising drug candidates, CTI BioPharma is at the forefront of cutting-edge research in the field of oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

8 Patents

#245 in Seattle, WA

#828 in Washington

#36,017 in US

Seattle, WA (US)
Seattle, WA, United States of America

Cti Biopharma Corp.

Forward Citations = 3

12 inventors:

goldMedal Anthony Deodaunia William (7 out of 11 patents)

silverMedal Brian William Dymock (4 out of 20 patents)

bronzeMedal Stephanie Eliane Blanchard (3 out of 13 patents)

4.  Harish Kumar Mysore Nagaraj (3 out of 7 patents)

5.  Anders Poulsen (3 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cti Biopharma Corp.. Retrieved from https://idiyas.com/company/cti-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…